REGN9533 / Regeneron - LARVOL DELTA

Phase 1 Safety and Tolerability Study of REGN9533 in Healthy Adults (clinicaltrials.gov) - P1 | N=72 | Completed | Sponsor: Regeneron Pharmaceuticals | Active, not recruiting ➔ Completed

Trial completion

Phase 1 Safety and Tolerability Study of REGN9533 in Healthy Adults (clinicaltrials.gov) - P1 | N=72 | Active, not recruiting | Sponsor: Regeneron Pharmaceuticals | Recruiting ➔ Active, not recruiting

Enrollment closed

Phase 1 Safety and Tolerability Study of REGN9533 in Healthy Adults (clinicaltrials.gov) - P1 | N=56 | Recruiting | Sponsor: Regeneron Pharmaceuticals | Not yet recruiting ➔ Recruiting

Enrollment open